Incentivized Smoking Cessation for Diabetics

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 22, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Smoking CessationDiabetes Mellitus, Type 2
Interventions
BEHAVIORAL

Financial incentives

Treatment arm participants will receive financial incentives ($20 per week) contingent on biochemically verified smoking abstinence submitted once daily for the time period allocated.

Trial Locations (2)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

Unknown

University of Strathclyde, Glasgow

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

University of Strathclyde

OTHER

collaborator

University College, London

OTHER

lead

University of Oklahoma

OTHER